SST and malignant colon neoplasm: Furthermore the results of Colucci et al. provided novel evidences that somatostatin can decrease COX-2 expression and enzyme function via activation SSTR3 or SSTR5 in human colon cancer cells, and suggests that these effects can contribute significantly to the inhibitory action of SST on cell growth [62].